These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 24314163)
1. [A comparative study of the effects of needle free (INJEX30) versus insulin pen injection on insulin absorption in diabetic patients]. Zhou MC; Wang Y; Dong YX; Sun Q; Li YX Zhonghua Nei Ke Za Zhi; 2013 Sep; 52(9):741-4. PubMed ID: 24314163 [TBL] [Abstract][Full Text] [Related]
2. [The effect of enteral nutritional suspension (diabetes) (TPF-DM) on blood glucose, serum insulin and lipids in patients with type 2 diabetes]. Li YX; Pan SH; Zeng JB; Yu K; Sun Q; Liu QY; Qin W; Zhang Q; Pan QR; Yu JC; Xu T; Han SM; Wang H Zhonghua Nei Ke Za Zhi; 2007 Mar; 46(3):193-6. PubMed ID: 17547798 [TBL] [Abstract][Full Text] [Related]
3. Addition of metformin to exogenous glucagon-like peptide-1 results in increased serum glucagon-like peptide-1 concentrations and greater glucose lowering in type 2 diabetes mellitus. Cuthbertson J; Patterson S; O'Harte FP; Bell PM Metabolism; 2011 Jan; 60(1):52-6. PubMed ID: 20152998 [TBL] [Abstract][Full Text] [Related]
4. Subcutaneous injection with an insulin pen. Insulin absorption and plasma concentrations of glucose and free insulin. de Meijer PH; Lutterman JA Neth J Med; 1990 Feb; 36(1-2):4-12. PubMed ID: 2179752 [TBL] [Abstract][Full Text] [Related]
5. Insulin pen needles: effects of extra-thin wall needle technology on preference, confidence, and other patient ratings. Aronson R; Gibney MA; Oza K; Bérubé J; Kassler-Taub K; Hirsch L Clin Ther; 2013 Jul; 35(7):923-933.e4. PubMed ID: 23790553 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of efficiency of insulin suppository formulations containing sodium salicylate or sodium cholate in insulin dependent diabetic patients. Hosny EA; Al-Marzouki ZM; Metwally ME; Souaida MY; Alshaik AR Boll Chim Farm; 2003 Oct; 142(8):361-6. PubMed ID: 15040468 [TBL] [Abstract][Full Text] [Related]
7. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion. Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098 [TBL] [Abstract][Full Text] [Related]
8. Humalog Mix25 offers better mealtime glycemic control in patients with type 1 or type 2 diabetes. Malone JK; Yang H; Woodworth JR; Huang J; Campaigne BN; Halle JP; Yale JF; Grossman LD Diabetes Metab; 2000 Dec; 26(6):481-7. PubMed ID: 11173719 [TBL] [Abstract][Full Text] [Related]
9. Oral spray insulin in treatment of type 2 diabetes: a comparison of efficacy of the oral spray insulin (Oralin) with subcutaneous (SC) insulin injection, a proof of concept study. Guevara-Aguirre J; Guevara M; Saavedra J; Mihic M; Modi P Diabetes Metab Res Rev; 2004; 20(6):472-8. PubMed ID: 15386822 [TBL] [Abstract][Full Text] [Related]
10. Plasma glucose response after intravenous injection of tolbutamide in insulin-treated type I and type II diabetic patients. Mokuda O; Murakami I; Ikeda T; Tominaga M; Mashiba H Exp Clin Endocrinol; 1988 Aug; 91(3):265-70. PubMed ID: 3075183 [TBL] [Abstract][Full Text] [Related]
11. Insulin administered by needle-free jet injection corrects marked hyperglycaemia faster in overweight or obese patients with diabetes. de Wit HM; Engwerda EE; Tack CJ; de Galan BE Diabetes Obes Metab; 2015 Nov; 17(11):1093-9. PubMed ID: 26259978 [TBL] [Abstract][Full Text] [Related]
12. [The comparison of insulin aspart and human soluble insulin used in insulin pump therapy in newly diagnosed type 2 diabetic patients]. Li YB; Liu J; Liao ZH; Liao Y; Deng WP; Weng JP Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(35):2472-6. PubMed ID: 16321271 [TBL] [Abstract][Full Text] [Related]
13. Comparison of usability and patient preference for insulin pen needles produced with different production techniques: "thin-wall" needles compared to "regular-wall" needles: an open-label study. Siegmund T; Blankenfeld H; Schumm-Draeger PM Diabetes Technol Ther; 2009 Aug; 11(8):523-8. PubMed ID: 19698066 [TBL] [Abstract][Full Text] [Related]
14. Effects of breakfast meal composition on second meal metabolic responses in adults with Type 2 diabetes mellitus. Clark CA; Gardiner J; McBurney MI; Anderson S; Weatherspoon LJ; Henry DN; Hord NG Eur J Clin Nutr; 2006 Sep; 60(9):1122-9. PubMed ID: 16670695 [TBL] [Abstract][Full Text] [Related]
15. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients. van der Wal PS; Draeger KE; van Iperen AM; Martini C; Aarsen M; Heine RJ Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393 [TBL] [Abstract][Full Text] [Related]
16. Comparative glycemic control, safety and patient ratings for a new 4 mm x 32G insulin pen needle in adults with diabetes. Hirsch LJ; Gibney MA; Albanese J; Qu S; Kassler-Taub K; Klaff LJ; Bailey TS Curr Med Res Opin; 2010 Jun; 26(6):1531-41. PubMed ID: 20429832 [TBL] [Abstract][Full Text] [Related]
17. Multiple insulin injections using a pen injector versus insulin pump treatment in young diabetic patients. Bak JF; Nielsen OH; Pedersen O; Beck-Nielsen H Diabetes Res; 1987 Nov; 6(3):155-8. PubMed ID: 3325220 [TBL] [Abstract][Full Text] [Related]
18. Optimal dose and timing of insulin Aspart to mimic first phase insulin response in patients with recently onset type 2 diabetes. Gredal C; Rosenfalck A; Dejgaard A; Hilsted J Diabetes Res Clin Pract; 2008 May; 80(2):293-8. PubMed ID: 18304675 [TBL] [Abstract][Full Text] [Related]
19. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues. Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931 [TBL] [Abstract][Full Text] [Related]
20. Twice-daily compared with once-daily insulin glargine in people with Type 1 diabetes using meal-time insulin aspart. Ashwell SG; Gebbie J; Home PD Diabet Med; 2006 Aug; 23(8):879-86. PubMed ID: 16911626 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]